Tirzepatide is a dual GIP and GLP-1 receptor agonist used in approved medicines for specific metabolic conditions. Approved uses vary according to the specific product and jurisdiction.

The Xeno Labs listing identifies a 10 mg strength, but the supplied information does not establish the dosage form, package quantity, or whether it corresponds to an approved medicinal presentation.

GORoids should verify the manufacturer’s documentation, exact formulation, storage requirements, labeling, and regulatory authorization before presenting additional medical claims.